Similar articles

• Drug evaluation and approval process in the European Union.

  San Miguel MT, Vargas E. San Miguel MT, et al. Arthritis Rheum. 2006 Feb 15;55(1):12-4. doi: 10.1002/art.21712. Arthritis Rheum. 2006. PMID: 16463405 No abstract available.
• [New drugs and European procedures of approval. The European Agency for the Evaluation of Medicinal Products' role].

  Ainsworth MA. Ainsworth MA. Ugeskr Laeger. 2003 Apr 14;165(16):1648-9. Ugeskr Laeger. 2003. PMID: 12756819 Danish.
• Researchers see a need for speed in EU trial approvals.

  Cressey D. Cressey D. Nat Med. 2008 Aug;14(8):794. doi: 10.1038/nm0808-794a. Nat Med. 2008. PMID: 18685580 No abstract available.
• Drug regulation in the European Union.

  Griffin JP. Griffin JP. Adverse Drug React Toxicol Rev. 2000 Aug;19(3):179-206. Adverse Drug React Toxicol Rev. 2000. PMID: 11059359 Review. No abstract available.
• [Does collaboration inside the European Union improve Finnish drug safety?].

  Palva E. Palva E. Duodecim. 2000;116(24):2810-1. Duodecim. 2000. PMID: 12077885 Review. Finnish. No abstract available.